BioWorld MedTech

May 17, 2012

The MDD Interview: Dealing with 'nasty disease states' creates opportunities for EKOS

Robert Hubert is president/CEO of EKOS (Bothell, Washington), bringing to EKOS more than 20 years of marketing, sales, and general management experience in a broad range of medical device companies, from start-up to Fortune 10. Read More

MedTech Investing Conference: For reimbursement, it's all about the effect on outcomes

EuroPCR 2012: FFR challenged even as FAME 2 fixes a gold standard

Financings roundup: Mitralign closes $35M 'D' round to support CE mark

Washington roundup: Threshold of evidence proves a sticking point for new CED

EuroPCR 2012 notebook: Medtronic IN.PACT studies show benefit for arteries

Deals roundup: Quality Systems acquires HIT firm Poseidon Group

HIT roundup: SynerMed partners with IEHIE to link patients, providers

Med-Tech Notes: Steinberg center installs Aquilion series

Patent watch: NeuroSigma acquires patent portfolio from TiNi Alloy

Grants roundup: HHS to give more than $181M to states to implement AIEs

Product Briefs

OraSure's HIV test gets BPAC recommendation

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...